Advertisement
Sections
Vantage | A diabetes drug Ozempic is going viral for the wrong reasons and that's a problem
As the battle between vanity and common sense rages on, Ozempic remains at the centre, feeding off our insecurities and challenging the very essence of what it means to be healthy

In a world obsessed with body image and the pursuit of the perfect physique, a new player has entered the scene -- Ozempic. Originally designed as a weekly injection to treat diabetes by lowering blood sugar levels, Ozempic has become the go-to elixir for those yearning for a future without fat.The year 2023 has marked a milestone for Ozempic, earning the title of a miracle drug. From celebrities to ordinary individuals, its use has spread like wildfire, positioning it as a key player in the quest for the perfect body.Evolution of body idealsOver the past decade, societal standards of the perfect female body have been heavily influenced by a godless alliance between Instagram, TikTok and the Kardashians. Ozempic has emerged as a solution for those who haven't been blessed with miracle genes, promising a future free from the shackles of excess weight.Notable personalities such as comedians Amy Schumer and Rosie O’Donnell, model and TikTok creator Remi Bader, NBA star Charles Barkley and even billionaire Elon Musk have openly admitted to using Ozempic. The trend is not limited to them, with other celebrities, including reality stars Khloe Kardashian and Kaeel Richards, are rumoured to be part of the Ozempic club.The Barbie dilemmaFor generations, the societal ideal of a woman's appearance has been shaped by the plastic doll -- Barbie. However, the pursuit of the perfect body has led many women down a path of self-loathing. Despite some progress, the pressure to conform to the thin ideal persists, affecting women of all shapes, sizes and backgrounds.The use of Ozempic has become so commonplace that it could soon be included in company-sponsored health plans in the US. This development could be a significant incentive for women in the workforce, potentially influencing career choices.While the road to achieving the Barbie-like figure has never been cheap, Ozempic and similar obesity drugs add a financial burden, costing upwards of $900 a month. Currently, less than half of large employers cover these drugs, but with around 18 per cent of big firms considering their inclusion, this may soon change.Ozempic has transcended personal choices and is making its mark as a corporate benefit. Similar to gym memberships in the past, Ozempic is now offered as part of employment packages, reflecting the unprecedented interest in this weight-loss drug.Pill versionFor those wary of injections, a pill version of Ozempic is on the horizon. This development could potentially make the drug more accessible, but it doesn't come without its drawbacks.Dark side of OzempicDespite its popularity, the Ozempic craze overlooks some serious pitfalls. A sudden surge in demand has led to a shortage of the drug originally intended for diabetic patients. Moreover, Ozempic comes with a laundry list of side effects, ranging from abdominal pain to an increase in heart rate. The fixation on looking "Insta-good" may be causing serious harm to health, as the pursuit of thinness clashes with common sense.As the battle between vanity and common sense rages on, Ozempic remains at the centre, feeding off our insecurities and challenging the very essence of what it means to be healthy.Views expressed in the above piece are personal and solely that of the author. They do not necessarily reflect Firstpost’s views.Read all the Latest News, Trending News, Cricket News, Bollywood News,India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.
First Published:Nov 16, 2023, 15:42:44 IST
Advertisement
Advertisement

When Manila and Tokyo draw a line, Beijing draws a red line
What should have been a routine maritime-boundary negotiation between Japan and the Philippines has become a contest over China’s power to veto its neighbours’ strategic choices
6 min read
Bangladesh gets a new envoy to reset its India ties
The selection of a serving foreign secretary underscores the seriousness with which Dhaka now views its relationship with New Delhi
3 min read
Escalation trap to an exit strategy: How can the Iran war end?
This war is no longer about outright victory; it is about finding an exit without appearing to lose
7 min read
India must seize its demographic dividend before it fades
Adequate funding for universal education, leak-proof exams and job creation are vital to leverage India's demographic dividend before it’s too late
4 min read
Bangladesh’s instability has sharpened India’s ‘Chicken Neck’ challenge
India could consider notifying a union territory around the Siliguri Corridor consisting of parts of all bordering districts
8 min read
Advertisement
Advertisement
